|
|
|
|
| Fabrice N. Vincent |
| Partner |
| San Francisco |
|
| Practice Areas Include: |
Personal Injury/Torts
Defective Products
Wrongful Deaths
Medical Malpractice
Environmental and Toxic Torts
International and Human Rights
Automobile Accidents
|
|
|
|
|
|
|
| Bar Information |
| |
Admitted to practice in California, 1992;
U.S. District Court, Northern District of California, Central District
of California, Eastern District of California, Ninth Circuit Court
of Appeals, 1992. |
|
|
| Education |
| |
Cornell Law School (J.D., cum laude,
1992); University of California at Berkeley (B.A., 1989). |
|
|
| Awards |
| |
"Northern California Super Lawyer," Law & Politics,
2006-2007. |
|
|
| Publications |
| |
Co-Author with Elizabeth J. Cabraser, “Class
Actions Fairness Act of 2005,” California Litigation, Vol.
18, No. 3 (2005); Co-Editor, California Class Actions Practice
and Procedures (2003-06); Co-Author, "Ethics and Admissibility:
Failure to Disclose Conflicts of Interest in and/or Funding of Scientific
Studies and/or Data May Warrant Evidentiary Exclusions," Mealey's
December Emerging Drugs Reporter (December 2002); Co-author, "The
Shareholder Strikes Back: Varied Approaches to Civil Litigation Claims
Are Available to Help Make Shareholders Whole," Mealey's
Emerging Securities Litigation Reporter (September 2002); Co-author, "Decisions
Interpreting California's Rules of Class Action Procedure," Survey
of State Class Action Law (ABA 2000-06), updated and re-published
in 5 Newberg on Class Actions (2001-06); Coordinating Editor
and Co-author of California section of the ABA State Class Action
Survey (2001-06); Co-Editor-In-Chief, Fen-Phen Litigation
Strategist (Leader Publications 1998-2000) and Author of "Off-Label
Drug Promotion Permitted" (Oct. 1999); Co-author, "The
Future of Prescription Drug Products Liability Litigation in a Changing
Marketplace," and "Six Courts Certify Medical Monitoring
Claims for Class Treatment," 29 Forum 4 (Consumer Attorneys
of California 1999); Co-author, "Class Certification of Medical
Monitoring Claims in Mass Tort Product Liability Litigation" (ALI-ABA
Course of Study 1999); Co-author, "How Class Proofs of
Claim in Bankruptcy Can Help in Medical Monitoring Cases," (Leader
Publications 1999); Co-author, Introduction, "Sanctioning Discovery
Abuses in the Federal Court," (LRP Publications 2000); "With
Final Approval, Diet Drug Class Action Settlement Avoids Problems
That Doomed Asbestos Pact," (Leader Publications 2000). |
|
|
| Member |
| |
State Bar of California; Bar Association
of San Francisco; American Bar Association; Association of Trial Lawyers
of America; Association of Business Trial Lawyers. |
|
|
|
|
|
|
Lieff
Cabraser Heimann & Bernstein, LLP
|
|
|
|
|
|
|
|
|
Copyright © 2007 Lieff Cabraser Heimann & Bernstein, LLP |
|
|
|
|
Merck
Agrees to Resolve U.S. VIOXX® Product Liability
Lawsuits
November 9, 2007
Merck & Co., Inc. announced that it has entered into an agreement to resolve
state and federal myocardial infarction (MI) and ischemic stroke claims already
filed against the Company in the United States. More... |
|
|
|
|